Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1988 Feb 15;66(4):135-43.
doi: 10.1007/BF01727781.

Dietary protein and atherogenesis

Affiliations
Review

Dietary protein and atherogenesis

C A Barth et al. Klin Wochenschr. .

Abstract

Different dietary proteins determine different serum cholesterol levels if fed in a semisynthetic diet to some, but not all, animal species. In one species, the rabbit, this metabolic response is elicited without adding high sucrose or cholesterol supplements that have to be added to rat or pig diets in order to cause a similar response. Eleven out of 13 studies show that casein and soy protein do not induce different serum cholesterol levels in normal man. More important, protein-induced differences of serum cholesterol concentrations have not been reported when appropriate nutritional methodology has been applied. We conclude that no protein-induced hypercholesterolemia is observed in primates, particularly not in the human species. Dietary recommendations urging the general public to reduce consumption of animal protein because of a higher atherogenicity are not supported by the present data. The biochemical basis of the metabolic responses has been studied by many investigators, but no convincing unifying concept has yet been identified. The recent observation of higher serum thyroxine concentrations following soy protein consumption (and vegetable protein in general) when compared to casein shed new light on this problem. This endocrine response explains a wide array of metabolic features of soy-fed rodents: the lower hepatic VLDL secretion, the higher hepatic HMG-CoA reductase activity, the higher hepatic apo B, E receptor activity, the higher fecal bile acid excretion, and finally the lower serum cholesterol concentrations.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Metabolism. 1984 Feb;33(2):129-31 - PubMed
    1. Horm Metab Res. 1983 Sep;15(9):449-52 - PubMed
    1. Ann Nutr Metab. 1986;30(5):281-8 - PubMed
    1. Atherosclerosis. 1985 Aug;56(2):247-50 - PubMed
    1. Am J Clin Nutr. 1978 Aug;31(8):1312-21 - PubMed

Publication types

Substances

LinkOut - more resources